Yi X. Shao

Tianjin, 300211, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Integrated transcriptomics and single-cell analysis identify ITGAX⁺ macrophages as key immunosuppressive factors in the prostate cancer tumor microenvironment.

Integrated transcriptomics and single-cell analysis identify ITGAX⁺ macrophages as key immunosuppressive factors in the prostate cancer tumor microenvironment.

Journal: Discover oncology
Published: September 26, 2025

Probucol inhibits palmitic acid-mediated renal calcium oxalate stone formation by targeting KLF5-PPARγ axis-mediated lipotoxicity.

Probucol inhibits palmitic acid-mediated renal calcium oxalate stone formation by targeting KLF5-PPARγ axis-mediated lipotoxicity.

Journal: Journal of pharmaceutical analysis
Published: June 03, 2025

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment.

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment.

Journal: The Prostate
Published: August 09, 2024

NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation.

NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation.

Journal: Discover oncology
Published: June 26, 2024

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.

Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.

Journal: Cell death & disease
Published: October 02, 2023

TEAD3 inhibits the proliferation and metastasis of prostate cancer via suppressing ADRBK2.

TEAD3 inhibits the proliferation and metastasis of prostate cancer via suppressing ADRBK2.

Journal: Biochemical and biophysical research communications
Published: February 16, 2023

Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.

Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer.

Journal: Cell death & disease
Published: September 28, 2022

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.

Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer.

Journal: Cell death & disease
Published: June 08, 2022

The cell cycle gene centromere protein K (CENPK) contributes to the malignant progression and prognosis of prostate cancer.

The cell cycle gene centromere protein K (CENPK) contributes to the malignant progression and prognosis of prostate cancer.

Journal: Translational cancer research
Published: October 07, 2021

Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3.

Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3.

Journal: Journal of Cancer
Published: April 01, 2021

A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy.

A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy.

Journal: Translational andrology and urology
Published: March 15, 2021

Microstructure Evolution of HSLA Pipeline Steels after Hot Uniaxial Compression.

Microstructure Evolution of HSLA Pipeline Steels after Hot Uniaxial Compression.

Journal: Materials (Basel, Switzerland)
Published: July 25, 2016
Showing 1-12 of 13

Last Updated: 09/26/2026